Volume 65, Issue 2, Pages (February 2004)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Reduced renal function in patients with simple renal cysts
Volume 54, Issue 2, Pages (August 1998)
Volume 66, Issue 1, Pages (July 2004)
Volume 55, Issue 2, Pages (February 1999)
Mycophenolate mofetil treatment for primary glomerular diseases
Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function  Susan E. Shoaf, Patricia Bricmont, Suresh.
Continuous renal replacement therapy in the critically ill patient
Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real?  S. Andrulli, S. Di Filippo, F. Locatelli 
Kamyar Kalantar-Zadeh  Kidney International 
Peripheral microvascular parameters in the nephrotic syndrome
Progression of diabetic nephropathy
How to interpret the eGFR in patients with small body surface area
Methotrexate in the urine
Volume 82, Issue 9, Pages (November 2012)
Volume 58, Issue 5, Pages (November 2000)
Comorbidity and confounding in end-stage renal disease
Volume 55, Issue 4, Pages (April 1999)
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment  Martina Franz, Wolfgang Woloszczuk, Walter.
Volume 70, Issue 11, Pages (December 2006)
Volume 56, Issue 3, Pages (September 1999)
Volume 87, Issue 2, Pages (February 2015)
Volume 60, Issue 3, Pages (September 2001)
Volume 66, Issue 3, Pages (September 2004)
Volume 67, Pages S48-S51 (January 2005)
Volume 58, Issue 2, Pages (August 2000)
Volume 76, Issue 5, Pages (September 2009)
Volume 62, Issue 1, Pages (July 2002)
Peritoneal dialysis adequacy and risk of death
Martin K. Kuhlmann, Martina Heckmann, Werner Riegel, Hans Köhler 
Volume 87, Issue 1, Pages (January 2015)
Günter Weiss, Florian Kronenberg  Kidney International 
Volume 76, Issue 3, Pages (August 2009)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Non-immunologic intervention in chronic allograft nephropathy
Volume 61, Issue 4, Pages (April 2002)
Eva Balint, Cory F. Marshall, Dr Stuart M. Sprague 
Reduced renal function in patients with simple renal cysts
Simvastatin in nephrotic syndrome
Volume 63, Issue 2, Pages (February 2003)
Counteracting progression of renal disease: A look into the future
Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients  Florian Kronenberg, Arno Lingenhel, Ulrich Neyer, Karl Lhotta, Paul König, Martin.
Volume 71, Issue 4, Pages (February 2007)
Homocysteine, renal function, and risk of cardiovascular disease
Volume 74, Issue 9, Pages (November 2008)
Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass 
Volume 63, Issue 2, Pages (February 2003)
Volume 69, Issue 1, Pages (January 2006)
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Reduced content of α subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes: Relationship with vascular hyporeactivity  Lorenzo.
Volume 60, Issue 6, Pages (December 2001)
Volume 75, Issue 4, Pages (February 2009)
Is it the low-protein diet or simply the salt restriction?
Volume 69, Issue 10, Pages (May 2006)
Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa 
The changing face of childhood nephrotic syndrome
Volume 64, Issue 4, Pages (October 2003)
Dana V. Rizk, David G. Warnock  Kidney International 
Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies  Michael Eikmans, Hans J. Baelde, Emile De Heer,
Prediction in idiopathic membranous nephropathy
Volume 67, Issue 4, Pages (April 2005)
Volume 57, Pages S44-S48 (April 2000)
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Volume 59, Issue 5, Pages (May 2001)
Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund 
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
Volume 56, Issue 6, Pages (December 1999)
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Volume 65, Issue 2, Pages 606-612 (February 2004) The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome  Florian Kronenberg, Arno Lingenhel, Karl Lhotta, Barbara Rantner, Martina F. Kronenberg, Paul König, Joachim Thiery, Michael Koch, Arnold von Eckardstein, Hans Dieplinger  Kidney International  Volume 65, Issue 2, Pages 606-612 (February 2004) DOI: 10.1111/j.1523-1755.2004.00418.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Frequency distribution of lipoprotein(a) [Lp(a)] serum concentrations in 207 patients with nephrotic syndrome and 274 healthy controls. Pearson's χ2 test P < 0.0001. Kidney International 2004 65, 606-612DOI: (10.1111/j.1523-1755.2004.00418.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Influence of proteinuria and renal function on lipoprotein(a) [Lp(a)] serum concentrations in patients with nephrotic syndrome. The 10th, 25th, 50th, 75th, and 90th percentile of Lp(a) serum concentrations in groups of patients stratified by the medians of proteinuria and creatinine clearance. No significant differences between the four groups were observed (Kruskal-Wallis test, P = 0.59). Kidney International 2004 65, 606-612DOI: (10.1111/j.1523-1755.2004.00418.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Median lipoprotein(a) [Lp(a)] serum concentrations in patients with nephrotic syndrome and controls stratified by six apo(a) isoform groups. Lp(a) concentrations were calculated for each expressed apo(a) isoform separately from the measured Lp(a) concentration by estimating the relative proportion of the two isoforms in the sodium dodecyl sulfate (SDS) agarose gel electrophoresis (see Methods section). Kidney International 2004 65, 606-612DOI: (10.1111/j.1523-1755.2004.00418.x) Copyright © 2004 International Society of Nephrology Terms and Conditions